About Robert-Bosch-Krankenhaus
Das Robert-Bosch-Krankenhaus auf dem Burgholzhof in Stuttgart ist ein Stiftungskrankenhaus, das auf eine private Initiative Robert Boschs aus dem Jahr 1915 zurückgeht.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Robert-Bosch-Krankenhaus
During the past decade, Robert-Bosch-Krankenhaus conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 20 clinical trials were completed, i.e. on
average, 35.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 10 clinical trials were completed. i.e. 55.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
2002-05-01
Unknown status
220
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
2002-06-01
2017-03-31
Completed
1,551
EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan
2003-09-01
2006-07-01
Completed
3,600
Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients
2004-07-01
2010-06-01
Completed
335
Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
2005-10-01
2015-06-01
Completed
825
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Robert-Bosch-Krankenhaus" #1 sponsor was "Goethe University" with 6 trials, followed by "Boehringer Ingelheim" with 5 trials
sponsored, "Aesculap AG" with 4 trials sponsored, "Celgene" with 4 trials sponsored and "German CLL Study Group"
with 4 trials sponsored. Other sponsors include 87 different institutions and
companies that sponsored additional 73 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Robert-Bosch-Krankenhaus"
#1 collaborator was "B.Braun Surgical SA" with 4 trials as a collaborator, "Bayer" with 3 trials as a collaborator, "AbbVie" with 2 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator and "Cancer Trials Ireland" with 2 trials as a collaborator. Other collaborators include 96 different institutions and companies that were
collaborators in the rest 94 trials.
Clinical Trials Conditions at Robert-Bosch-Krankenhaus
According to Clinical.Site data, the most researched conditions in "Robert-Bosch-Krankenhaus" are
"Acute Myeloid Leukemia" (6 trials), "Coronary Artery Disease" (6 trials), "Aortic Valve Stenosis" (5 trials), "Leukemia" (5 trials) and "Chronic Heart Failure" (3 trials). Many other conditions were trialed in "Robert-Bosch-Krankenhaus" in a lesser frequency.
Clinical Trials Intervention Types at Robert-Bosch-Krankenhaus
Most popular intervention types in "Robert-Bosch-Krankenhaus" are "Drug" (73 trials), "Other" (18 trials), "Device" (16 trials), "Procedure" (15 trials) and "Biological" (13 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (16 trials), "Carboplatin" (4 trials), "cyclophosphamide" (4 trials), "radiation therapy" (4 trials) and "Azacitidine" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Robert-Bosch-Krankenhaus
The vast majority of trials in "Robert-Bosch-Krankenhaus" are
110 trials for "All" genders and 5 trials for "Female" genders.
Clinical Trials Status at Robert-Bosch-Krankenhaus
Currently, there are NaN active trials in "Robert-Bosch-Krankenhaus".
undefined are not yet recruiting,
20 are recruiting,
19 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 54 completed trials in Robert-Bosch-Krankenhaus,
undefined suspended trials,
and 15 terminated clinical trials to date.
Out of the total trials that were conducted in Robert-Bosch-Krankenhaus, 3 "Phase 1"
clinical trials were conducted, 30 "Phase 2" clinical
trials and 46 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 17 trials that are defined as “Not Applicable".
Departments of Robert-Bosch-Krankenhaus
Robert-Bosch-Krankenhaus has several departments that took part in Clinical trials: "Robert Bosch Krankenhaus; Pneumologie und pneumologische Onkologie" - 6 trials, "Robert-Bosch-Krankenhaus; Hämatologie, Onkologie und Palliativmedizin" - 5 trials, "Robert-Bosch-Krankenhaus, Zentrum für Innere Medizin" - 2 trials
Departments List